Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Epigenetic Reprogramming in Relapse/Refractory AML

NCT03263936

Conditions
Acute Myelogenous Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View all 33 locations
View Trial Details
Completed

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

NCT02512926

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

NCT04201262

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Miami, Florida, United States
View all 41 locations
View Trial Details
Completed

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

NCT04447755

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Children's Hospital of Colorado ( Site 0110) Aurora, Colorado, United States
  • Cleveland Clinic ( Site 0119) Cleveland, Ohio, United States
  • Monroe Carell Jr. Children's Hospital at Vanderbilt ( Site 0102) Nashville, Tennessee, United States
  • Mary Crowley Cancer Research Center ( Site 0107) Dallas, Texas, United States
View all 49 locations
View Trial Details
Completed

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

NCT05216835

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Miami, Florida, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site New York, United States
View all 14 locations
View Trial Details
Completed

A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

NCT05470140

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Healthcare Palo Alto, California, United States
  • Norton Health Care Louisville, Kentucky, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

NCT01909934

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • UZ Leuven Leuven, Belgium
View all 40 locations
View Trial Details

Related conditions